Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/22713
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2021-11-18T07:51:55Z | - |
dc.date.available | 2021-11-18T07:51:55Z | - |
dc.date.issued | 1999 | - |
dc.identifier.citation | Akalın, H. vd. (1999). "Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU". Intensive Care Medicine, 25(9), 1010-1012. | en_US |
dc.identifier.issn | 0342-4642 | - |
dc.identifier.uri | https://doi.org/10.1007/s001340050998 | - |
dc.identifier.uri | https://link.springer.com/article/10.1007%2Fs001340050998 | - |
dc.identifier.uri | http://hdl.handle.net/11452/22713 | - |
dc.description.abstract | In this study, the effects of alternate use of imipenem and cef-operazone/sulbactam(CFP/Sul) on antibiotic resistance in the intensive care unit (ICU) were investigated, Between 1 April 1993 and 1 April 1994, the infectious diseases consultant saw patients when required and there was no alternative therapy for antibiotics. For the following 2 years, the same consultant followed up each patient from admission to discharge by daily visits to the ICU and an alternative therapy protocol was initiated, The most common microorganisms were found to be Acinetobacter baumannii and Staphylococcus aureus, followed by Pseudomonas aeruginosa and Klebsiella pneumoniae, respectively, in the two periods. This study demonstrated that sensitivity rates of imipenem, ciprofloxacin and aminoglycosides were improved as a result of this protocol. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | General & internal medicine | en_US |
dc.subject | Alternate use of antibiotics | en_US |
dc.subject | Resistance | en_US |
dc.subject.mesh | Anti-bacterial agents | en_US |
dc.subject.mesh | Bacteria | en_US |
dc.subject.mesh | Bacterial infections | en_US |
dc.subject.mesh | Chi-square distribution | en_US |
dc.subject.mesh | Clinical protocols | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Intensive care | en_US |
dc.subject.mesh | Microbial sensitivity tests | en_US |
dc.subject.mesh | Referral and consultation | en_US |
dc.subject.mesh | Time factors | en_US |
dc.title | Influences of alternate therapy protocol and continuous infectious disease consultation on antibiotic susceptibility in ICU | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000082918200026 | tr_TR |
dc.identifier.scopus | 2-s2.0-0032822872 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Anesteziyoloji ve Reanimasyon Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-4820-2288 | tr_TR |
dc.identifier.startpage | 1010 | tr_TR |
dc.identifier.endpage | 1012 | tr_TR |
dc.identifier.volume | 25 | tr_TR |
dc.identifier.issue | 9 | tr_TR |
dc.relation.journal | Intensive Care Medicine | en_US |
dc.contributor.buuauthor | Akalın, Halis | - |
dc.contributor.buuauthor | Kahveci, Ferda Şöhret | - |
dc.contributor.buuauthor | Özakın, Cüneyt | - |
dc.contributor.buuauthor | Helvacı, Safiye | - |
dc.contributor.buuauthor | Gedikoğlu, Suna | - |
dc.contributor.buuauthor | Kutlay, Oya | - |
dc.contributor.buuauthor | Töre, Okan | - |
dc.identifier.pubmed | 10501761 | tr_TR |
dc.subject.wos | Critical care medicine | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.contributor.scopusid | 6602405968 | tr_TR |
dc.contributor.scopusid | 57200678942 | tr_TR |
dc.contributor.scopusid | 6602103491 | tr_TR |
dc.contributor.scopusid | 6603407548 | tr_TR |
dc.contributor.scopusid | 6602199747 | tr_TR |
dc.contributor.scopusid | 6505909596 | tr_TR |
dc.subject.scopus | Antimicrobial Stewardship; Carbapenems; Inappropriate Prescribing | en_US |
dc.subject.emtree | Amikacin | en_US |
dc.subject.emtree | Aminoglycoside | en_US |
dc.subject.emtree | Cefoperazone | en_US |
dc.subject.emtree | Ceftazidime | en_US |
dc.subject.emtree | Ceftriaxone | en_US |
dc.subject.emtree | Ciprofloxacin | en_US |
dc.subject.emtree | Gentamicin | en_US |
dc.subject.emtree | Imipenem | en_US |
dc.subject.emtree | Sulbactam | en_US |
dc.subject.emtree | Acinetobacter baumannii | en_US |
dc.subject.emtree | Antibiotic sensitivity | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical protocol | en_US |
dc.subject.emtree | Drug choice | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Infection control | en_US |
dc.subject.emtree | Intensive care unit | en_US |
dc.subject.emtree | Klebsiella pneumoniae | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | Staphylococcus aureus | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.